Acute kidney injury due to anti-tuberculosis drugs: A five-year experience in an aging population

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Chang, Chia Hao ^a   Chen, Yen Fu ^a   Wu, Vin Cent ^a   Shu, Chin Chung ^a   Lee, Chih Hsin ^b   Wang, Jann Yuan ^a   Lee, Li Na ^a   Yu, Chong Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI HOSPITAL   (Taiwan)

Author keywords

Acute kidney injury; Anti tuberculosis drug; Fever; Rash; Rifampin

Indexed keywords

CREATININE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; AGING; ARTHRALGIA; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; POPULATION RESEARCH; RASH; RETROSPECTIVE STUDY; SEX DIFFERENCE; TUBERCULOSIS; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; COMPLICATION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; TIME; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS;

EID: 84892412208     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-23     Document Type: Article

References (30)

1. Lonnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Sem Respir Crit Med 2008, 29(5):481-491.
2. World Health Organization Global Tuberculosis Report 2012 2012, Geneva, World Health Organization.
3. Centers for Disease Control, R.O.C. (Taiwan) Taiwan tuberculosis control report 2011 2011, Taiwan, Centers for Disease Control, R.O.C. (Taiwan).
4. De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features. Am J Kidney Dis: Off J Nat Kidney Found 1998, 31(1):108-115.
5. Trainin EB, Turin RD, Gomez-Leon G. Acute renal insufficiency complicating isoniazid therapy. Int J Pediatric Nephrol 1981, 2(1):53-54.
6. Kwon SH, Kim JH, Yang JO, Lee EY, Hong SY. Ethambutol-induced acute renal failure. Nephrol Dial Transpl: Off Publ European Dial Transpl Assoc European Renal Assoc 2004, 19(5):1335-1336.
7. Kumar S, Mehta JA, Trivedi HL. Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis. Chest 1976, 70(4):564-565. 10.1378/chest.70.4.564, 824103.
8. Qunibi WY, Godwin J, Eknoyan G. Toxic nephropathy during continuous rifampin therapy. Southern Med J 1980, 73(6):791-792. 10.1097/00007611-198006000-00034, 7394612.
9. Winter RJ, Banks RA, Collins CM, Hoffbrand BI. Rifampicin induced light chain proteinuria and renal failure. Thorax 1984, 39(12):952-953. 10.1136/thx.39.12.952, 459960, 6440306.
10. Soffer O, Nassar VH, Campbell WG, Bourke E. Light chain cast nephropathy and acute renal failure associated with rifampin therapy. Renal disease akin to myeloma kidney. Am J Med 1987, 82(5):1052-1056. 10.1016/0002-9343(87)90174-4, 3107382.
11. Covic A, Goldsmith DJ, Segall L, Stoicescu C, Lungu S, Volovat C, Covic M. Rifampicin-induced acute renal failure: a series of 60 patients. Nephrol Dial Transpl :Off Publ European Dial Transpl Assoc European Renal Assoc 1998, 13(4):924-929.
12. Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients. Am J kidney Dis: Off J Nat Kidney Found 2002, 40(4):690-696.
13. Schubert C, Bates WD, Moosa MR. Acute tubulointerstitial nephritis related to antituberculous drug therapy. Clin Nephrol 2010, 73(6):413-419. 10.5414/CNP73413, 20497752.
14. Kruger B, Benck U, Singer T, Kramer BK. Drug-induced impairment of renal function. Deutsche medizinische Wochenschrift (1946) 2012, 137(38):1873-1877.
15. Chen D, Luo C, Tang Z, Zhou Y, Chen H, Zeng C, Liu Z. Delayed renal function recovery from drug-induced acute interstitial nephritis. Am J Med Sci 2012, 343(1):36-39. 10.1097/MAJ.0b013e3182350362, 22143122.
16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit (London, England) 2007, 11(2):R31.
17. Luh K-TE. Taiwan guidelines for TB diagnosis and treatment 2013, Taipei, Taiwan: Centers for Disease Control, R.O.C. (Taiwan), 5.
18. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Int Med 2009, 24(7):783-788.
19. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J kidney Dis: Off J Nat Kidney Found 2002, 39(2 Suppl 1):S1-S266. National Kidney Foundation.
20. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Med 2006, 174(8):935-952.
21. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change?. J Am Soc Nephrol: JASN 2003, 14(8):2178-2187.
22. Chan WC, O'Mahoney MG, Yu DY, Yu RY. Renal failure during intermittent rifampicin therapy. Tubercle 1975, 56(3):191-198. 10.1016/0041-3879(75)90051-3, 129898.
23. Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int 2010, 77(11):956-961. 10.1038/ki.2010.89, 20336051.
24. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001, 60(2):804-817. 10.1046/j.1523-1755.2001.060002804.x, 11473672.
25. Prakash J, Sen D, Kumar NS, Kumar H, Tripathi LK, Saxena RK. Acute renal failure due to intrinsic renal diseases: review of 1122 cases. Renal Fail 2003, 25(2):225-233.
26. Thong BY. Clinical applications of drug desensitization in the asia-pacific region. Asia Pacific Allergy 2011, 1(1):2-11. 10.5415/apallergy.2011.1.1.2, 3206230, 22053290.
27. Kim JH, Kim HB, Kim BS, Hong SJ. Rapid oral desensitization to isoniazid, rifampin, and ethambutol. Allergy 2003, 58(6):540-541. 10.1034/j.1398-9995.2003.00152.x, 12757467.
28. Matz J, Borish LC, Routes JM, Rosenwasser LJ. Oral desensitization to rifampin and ethambutol in mycobacterial disease. Am J Respir Crit Med 1994, 149(3 Pt 1):815-817.
29. Holland CL, Malasky C, Ogunkoya A, Bielory L. Rapid oral desensitization to isoniazid and rifampin. Chest 1990, 98(6):1518-1519. 10.1378/chest.98.6.1518, 2245698.
30. Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T. Desensitization therapy for allergic reactions of antituberculous drugs-evaluation of desensitization therapy according to the guideline of the Japanese society for tuberculosis. Kekkaku: Tuber 2000, 75(12):699-704.